Physician profile
Syed S Ashraf
NPI 1477596104
$1,207.00
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.74 · 2020: $16.88 · 2021: $13.33 · 2022: $156 · 2023: $19.37 · 2024: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $840 · Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $840.24 |
| Food and Beverage | $124.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $945.16 | 2024 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $83.17 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $30.62 | 2022 | |
| Novo Nordisk INC | $30.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.07 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.79 | 2022 | |
| Abbott Laboratories | $19.37 | 2023 | Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $16.88 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.45 | 2019 | |
| Amgen INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ashraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.